{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T16:53:11Z","timestamp":1783788791274,"version":"3.55.0"},"reference-count":18,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2018]]},"DOI":"10.3960\/jslrt.18002","type":"journal-article","created":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T22:20:35Z","timestamp":1523571635000},"page":"102-106","source":"Crossref","is-referenced-by-count":12,"title":["Colonal monomorphic epitheliotropic intestinal T-cell lymphoma with                    novel phenotype of cytoplasmic CD3 expression"],"prefix":"10.3960","volume":"58","author":[{"given":"Yumi","family":"Aoyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Tsunemine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriko","family":"Zushi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Maruoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiichi","family":"Kodaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoo","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Swerdlow                            SH,                                Campo                            E,                                Pileri                            SA                    <i>et al.<\/i> The 2016 revision of the World Health Organization                    classification of lymphoid neoplasms. Blood. 2016; 127: 2375-2390.","DOI":"10.1182\/blood-2016-01-643569"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 van                                de Water                            JMW,                                Cillessen                            SAGM,                                Visser                            OJ                    <i>et al.<\/i> Enteropathy associated T-cell lymphoma and its precursor                    lesions. Best Pract Res Clin Gastroenterol. 2010; 24: 43-56.","DOI":"10.1016\/j.bpg.2009.11.002"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Pathologists                            LSGJ. The World                    Health Organization classification of malignant lymphomas in Japan: incidence of                    recently recognized entities. Pathol Int. 2000; 50: 696-702.","DOI":"10.1046\/j.1440-1827.2000.01108.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Tse                            E,                                Gill                            H,                                Loong                            F                    <i>et al.<\/i> Type II enteropathy-associated T-cell lymphoma: a                    multicenter analysis from the Asia Lymphoma Study Group. Am J Hematol. 2012; 87:                    663-668.","DOI":"10.1002\/ajh.23213"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Delabie                            J,                                Holte                            H,                                Vose                            JM                    <i>et al.<\/i> Enteropathy-associated T-cell lymphoma: clinical and                    histological findings from the international peripheral T-cell lymphoma project.                    Blood. 2011; 118: 148-155.","DOI":"10.1182\/blood-2011-02-335216"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Ito                            K,                                Shimizu                            N,                                Watanabe                            K                    <i>et al.<\/i> Analysis of viral infection by multiplex polymerase                    chain reaction assays in patients with liver dysfunction. Intern Med. 2013; 52:                    201-211.","DOI":"10.2169\/internalmedicine.52.8206"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 McElroy                            MK,                                Read                            WL,                                Harmon                            GS                    <i>et al.<\/i> A unique case of an indolent CD56-positive T-cell                    lymphoproliferative disorder of the gastrointestinal tract: a lesion potentially                    misdiagnosed as natural killer\/T-cell lymphoma. Ann Diagn Pathol. 2011; 15:                    370-375.","DOI":"10.1016\/j.anndiagpath.2010.05.007"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Cheroutre                            H,                                Lambolez                            F,                                Mucida                            D. The light and                    dark sides of intestinal intraepithelial lymphocytes. Nat Rev Immunol. 2011; 11:                    445-456.","DOI":"10.1038\/nri3007"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Weiss                            A,                                Stobo                            JD. Requirement                    for the coexpression of T3 and the T cell antigen receptor on a malignant human                    T cell line. J Exp Med. 1984; 160: 1284-1299.","DOI":"10.1084\/jem.160.5.1284"},{"key":"10","unstructured":"10 Alarcon                            B,                                Berkhout                            B,                                Breitmeyer                            J                    <i>et al.<\/i> Assembly of the human T cell receptor-CD3 complex takes                    place in the endoplasmic reticulum and involves intermediary complexes between                    the CD3-gamma.delta.epsilon core and single T cell receptor alpha or beta                    chains. J Biol Chem. 1988; 263: 2953-2961."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Kato                            A,                                Takiuchi                            Y,                                Aoki                            K                    <i>et al.<\/i> Enteropathy-associated T-cell lymphoma type II                    complicated by autoimmune hemolytic anemia. J Clin Exp Hematop. 2011; 51:                    119-123.","DOI":"10.3960\/jslrt.51.119"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Tanaka                            H,                                Ambiru                            S,                                Nakamura                            S                    <i>et al.<\/i> Successful diagnosis of type II enteropathy-associated                    T-cell lymphoma using flow cytometry and the cell block technique of celomic                    fluid manifesting as massive pyoid ascites that could not be diagnosed via                    emergency laparotomy. Intern Med. 2014; 53: 129-133.","DOI":"10.2169\/internalmedicine.53.1268"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Tomita                            S,                                Kikuti                            YY,                                Carreras                            J                    <i>et al.<\/i> Genomic and immunohistochemical profiles of                    enteropathy-associated T-cell lymphoma in Japan. Mod Pathol. 2015; 28:                    1286-1296.","DOI":"10.1038\/modpathol.2015.85"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Pipkin                            ME,                                Rao                            A,                                Lichtenheld                            MG. The                    transcriptional control of the perforin locus. Immunol Rev. 2010; 235: 55-72.","DOI":"10.1111\/j.0105-2896.2010.00905.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Daum                            S,                                Ullrich                            R,                                Heise                            W                    <i>et al.<\/i> Intestinal non-Hodgkin\u2019s lymphoma: a multicenter                    prospective clinical study from the German Study Group on Intestinal                    non-Hodgkin\u2019s Lymphoma. J Clin Oncol. 2003; 21: 2740-2746.","DOI":"10.1200\/JCO.2003.06.026"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Sieniawski                            M,                                Angamuthu                            N,                                Boyd                            K                    <i>et al.<\/i> Evaluation of enteropathy-associated T-cell lymphoma                    comparing standard therapies with a novel regimen including autologous stem cell                    transplantation. Blood. 2010; 115: 3664-3670.","DOI":"10.1182\/blood-2009-07-231324"},{"key":"17","doi-asserted-by":"crossref","unstructured":"18 Advani                            RH,                                Ansell                            SM,                                Lechowicz                            MJ                    <i>et al.<\/i> A phase II study of cyclophosphamide, etoposide,                    vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front                    line therapy for patients with peripheral T-cell lymphoma (PTCL): final results                    from the T- cell consortium trial. Br J Haematol. 2016; 172: 535-544.","DOI":"10.1111\/bjh.13855"},{"key":"18","doi-asserted-by":"crossref","unstructured":"19 Pellegrini                            C,                                Dodero                            A,                                Chiappella                            A                    <i>et al.<\/i>. A phase II study on the role of gemcitabine plus                    romidepsin (GEMRO regimen) in the treatment of relapsed\/refractory peripheral                    T-cell lymphoma patients. J Hematol Oncol. 2016; 9: 38.","DOI":"10.1186\/s13045-016-0266-1"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/58\/2\/58_18002\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,7,14]],"date-time":"2018-07-14T06:15:11Z","timestamp":1531548911000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/58\/2\/58_18002\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.18002","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}